Tuesday was a down day on Wall Street with stocks getting walloped across the board. Concerns over China's economy and the possibility that several big U.S. banks could see their credit ratings downgraded weighed on sentiment.
While the selling pressure was widespread for most of the session, healthcare stocks outperformed thanks to a few big movers.
Overnight, data from China showed exports from the world's second-largest economy fell 14.5% year-over-year in July, while imports dropped 12.4%.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"The trade data from China was undoubtedly disappointing as it once again showed sluggish demand both domestically and externally," says Craig Erlam, senior market analyst at OANDA. China's economy is clearly in need of a boost, but it's likely authorities will engage in small, targeted measures that won't boost confidence among investors or households, Erlam adds.
Moody's lowers credit ratings for regional lenders, puts bigger banks under review
Meanwhile, Moody's Investors Services late Monday lowered the credit ratings for several regional lenders, including Pinnacle Financial Partners (PNFP, -2.1%) and M&T Bank (MTB, -1.5%). The ratings agency also said it is reviewing ratings for a number of larger U.S. banks, including Bank of New York Mellon (BK, -1.3%) and State Street (STT, -1.6%). The news sent shockwaves through the financial sector, with Goldman Sachs (GS, -2.1%) and JPMorgan Chase (JPM, -0.6%) being two of the worst Dow Jones stocks today.
"The development, which comes roughly five months after a handful of regional banks hit the skids, has sparked renewed concerns about the potential for additional bank failures and consolidations," says José Torres, senior economist at Interactive Brokers.
Additionally, the headlines hit as investors are trying to determine whether or not the Federal Reserve will continue to raise interest rates. "To that end, the Consumer Price Index (CPI) data to be released this Thursday could be a significant driver of investor sentiment and the outlook for the Fed's monetary policy," Torres adds.
Eli Lilly, Novo Nordisk pop on weight-loss drug news
Investors also took in the latest batch of earnings reports. On the positive side of the ledger, Eli Lilly (LLY) popped 14.9% after the drugmaker reported higher-than-expected second-quarter earnings of $2.11. Plus, revenue of $8.3 billion beat estimates thanks in part to strong sales of Eli Lilly's diabetes drug Mounjaro. LLY also got a boost after Novo Nordisk (NVO, +17.2%) said its obesity drug Wegovy reduced the chance of heart attacks by 20% in subjects who participated in a trial.
The data removes an "overhang" for the obesity treatment landscape, says BofA Securities analyst Geoff Meacham. The analyst, who reiterated his Buy rating on LLY, added that "today's results bolsters our confidence in the obesity commercial opportunity."
At the other end of the spectrum, Beyond Meat (BYND) tumbled 14.3% after the plant-based protein maker reported earnings. While the company reported a narrower-than-expected second-quarter loss of 83 cents per share, revenue of $102.1 million – down 30% on a year-over-year basis – came in below estimates. BYND also gave lower-than-anticipated full-year revenue guidance.
As for the major indexes, while they finished well off their intraday lows, the blue chip Dow Jones Industrial Average still closed down 0.5% to 35,314. The broader S&P 500 shed 0.4% to 4,499, and the tech-heavy Nasdaq Composite fell 0.8% to 13,884.
Related Content
-
Stocks Slip to Start Fed Week: Stock Market TodayWhile a rate cut is widely expected this week, uncertainty is building around the Fed's future plans for monetary policy.
-
December Fed Meeting: Live Updates and CommentaryThe December Fed meeting is one of the last key economic events of 2025, with Wall Street closely watching what Chair Powell & Co. will do about interest rates.
-
This Is Why Investors Shouldn't Romanticize BitcoinInvestors should treat bitcoin as the high-risk asset it is. A look at the data indicates a small portfolio allocation for most investors would be the safest.
-
Crypto Trends to Watch in 2026Cryptocurrency is still less than 20 years old, but it remains a fast-moving (and also maturing) market. Here are the crypto trends to watch for in 2026.
-
If You'd Put $1,000 Into Coca-Cola Stock 20 Years Ago, Here's What You'd Have TodayEven with its reliable dividend growth and generous stock buybacks, Coca-Cola has underperformed the broad market in the long term.
-
If You Put $1,000 into Qualcomm Stock 20 Years Ago, Here's What You Would Have TodayQualcomm stock has been a big disappointment for truly long-term investors.
-
If You'd Put $1,000 Into Home Depot Stock 20 Years Ago, Here's What You'd Have TodayHome Depot stock has been a buy-and-hold banger for truly long-term investors.
-
What the Rich Know About Investing That You Don'tPeople like Warren Buffett become people like Warren Buffett by following basic rules and being disciplined. Here's how to accumulate real wealth.
-
Stocks Swing in Volatile Session: Stock Market Today
The main indexes fell sharply in early trading on rising China tensions, but rebounded thanks to encouraging bank earnings.
-
Dow Adds 587 Points as Stocks Bounce: Stock Market TodayThe main indexes rebounded sharply Monday after President Trump took a calmer stance toward China.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
